Identification of immunodominant linear B-cell epitopes within the major outer membrane protein of Chlamydia trachomatis

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 11, 2010, Pages 771-778

  Zhu, Shanli ^a   Chen, Jun ^a   Zheng, Meixia ^a   Gong, Wenci ^a   Xue, Xiangyang ^a   Li, Wenshu ^a   Zhang, Lifang ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

B cell epitope; Chlamydia trachomatis; major outer membrane protein (MOMP)

Indexed keywords

ANTISERUM; BACTERIUM ANTIBODY; EPITOPE; HYBRID PROTEIN; OUTER MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; HELA CELL; HUMAN; IMMUNIZATION; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE; SEQUENCE HOMOLOGY; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BLOTTING, WESTERN; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, B-LYMPHOCYTE; FEMALE; HELA CELLS; HUMANS; IMMUNE SERA; IMMUNIZATION; IMMUNODOMINANT EPITOPES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

CHLAMYDIA TRACHOMATIS; ESCHERICHIA COLI; MURINAE; MUS;

EID: 78049466698     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq087     Document Type: Article

References (34)

1. World Health Organization (WHO). Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. Geneva, Switzerland: WHO, 2001.
2. Joyee AG, Thyagarajan SP, Reddy EV, Venkatesan C and Ganapathy M. Genital chlamydial infection in STD patients: its relation to HIV infection. Indian J Med Microbiol 2005, 23:37-40.
3. Simonetti AC, Melo JH, de Souza PR, Bruneska D and de Lima Filho JL. Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor. Microbes Infect 2009, 11:435-442.
4. Denks K, Spaeth EL, Jõers K, Randoja R, Talpsep T, Ustav M and Kurg R. Coinfection of Chlamydia trachomatis, Ureaplasma urealyticum and human papillomavirus among patients attending STD clinics in Estonia. Scand J Infect Dis 2007, 39:714-718.
5. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT and Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 2004, 72:1843-1855.
6. Summersgill JT, Sahney NN, Gaydos CA, Quinn TC and Ramirez JA. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect Immun 1995, 63:2801-2803.
7. Volp K, Mathews S, Timms P and Hafner L. Peptide immunization of guinea pigs against Chlamydia psittaci (GPIC agent) infection induces good vaginal secretion antibody response, in vitro neutralization and partial protection against live challenge. Immunol Cell Biol 2001, 79:245-250.
8. Kubo A and Stephens RS. Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target. Mol Microbiol 2000, 38:772-780.
9. Swanson KA, Taylor LD, Frank SD, Sturdevant GL, Fischer ER, Carlson JH and Whitmire WM, et al. Chlamydia trachomatis polymorphic membrane protein D is an oligomeric autotransporter with a higher-order structure. Infect Immun 2009, 77:508-516.
10. Hoelzle LE, Hoelzle K and Wittenbrink MM. Expression of the major outer membrane protein (MOMP) of Chlamydophila abortus, Chlamydophila pecorum, and Chlamydia suis in Escherichia coli using an arabinose-inducible plasmid vector. J Vet Med B Infect Dis Vet Public Health 2003, 50:383-589.
11. Ortiz L, Angevine M, Kim SK, Watkins D and DeMars R. T-cell epitopes in variable segments of Chlamydia trachomatis major outer membrane protein elicit serovar-specific immune responses in infected humans. Infect Immun 2000, 68:1719-1723.
12. Kim SK, Angevine M, Demick K, Ortiz L, Rudersdorf R, Watkins D and DeMars R. Induction of HLA class I-restricted CD8+CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections. J Immunol 1999, 162:6855-6866.
13. Kim SK, Devine L, Angevine M, DeMars R and Kavathas PB. Direct detection and magnetic isolation of Chlamydia trachomatis major outer membrane protein-specific CD8+CTLs with HLA class I tetramers. J Immunol 2000, 165:7285-7292.
14. Qu Z, Cheng X, de la Maza LM and Peterson EM. Analysis of the humoral response elicited in mice by a chimeric peptide representing variable segments I and IV of the major outer membrane protein of Chlamydia trachomatis. Vaccine 1994, 12:557-564.
15. Batteiger BE. The major outer membrane protein of a single Chlamydia trachomatis Serovar can possess more than one serovar-specific epitope. Infect Immun 1996, 64:542-547.
16. Suchland RJ, Eckert LO, Hawes SE and Stamm WE. Longitudinal assessment of infecting serovars of Chlamydia trachomatis in Seattle public health clinics: 1988-1996. Sex Transm Dis 2003, 30:357-361.
17. Petrovay F, Balla E, Németh I and Gönczöl E. Genotyping of Chlamydia trachomatis from the endocervical specimens of high-risk women in Hungary. J Med Microbiol 2009, 58:760-764.
18. Donati M, Di Francesco A, D'Antuono A, Pignanelli S, Shurdhi A, Moroni A and Baldelli R, et al. Chlamydia trachomatis serovar distribution and other concurrent sexually transmitted infections in heterosexual men with urethritis in Italy. Eur J Clin Microbiol Infect Dis 2009, 28:523-526.
19. Zhu S, Shi Z, Wang P, Li W and Zhang L. Prediction of the B cell epitopes for the major outer membrane protein of Chlamydia trachomatis. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2008, 25:1397-1400.
20. Garnier J, Gibrat JF and Robson B. GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol 1996, 266:540-553.
21. Hoop TP and Woods KR. Prediction of antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 1981, 78:3824-3828.
22. Zimmerman JM, Eliezer N and Simha R. The characterization of amino acid sequences in proteins by statistical methods. J Theor Biol 1968, 21:170-201.
23. Diederichs K, Freigang J, Umhau S, Zeth K and Breed J. Prediction by a neural network of outer membrane-β-strand protein topology. Protein Sci 1998, 7:2413-2420.
24. Kolaskar AS and Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990, 276:172-174.
25. Barlow DJ, Edwards MS and Thornton JM. Continuous and discontinuous protein antigenic determinants. Nature 1986, 322:747-748.
26. Peterson EM, Zhong GM, Carlson E and de la Maza LM. Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity. Infect Immun 1988, 56:885-891.
27. Rodríguez-Marañón MJ, Bush RM, Peterson EM, Schirmer T and de la Maza LM. Prediction of the membrane-spanning beta-strands of the major outer membrane protein of Chlamydia. Protein Sci 2002, 11:1854-1861.
28. Mygind P, Christiansen G, Persson K and Birkelund S. Detection of Chlamydia trachomatis-specific antibodies in human sera by recombinant major outer-membrane protein polyantigens. J Med Microbiol 2000, 49:457-465.
29. Stothard DR, Boguslawski G and Jones RB. Phylogenetic analysis of the Chlamydia trachomatis major outer membrane protein and examination of potential pathogenic determinants. Infect Immun 1998, 66:3618-3625.
30. Hafner LM and McNeilly C. Vaccines for Chlamydia infections of the female genital tract. Future Microbiol 2008, 3:67-77.
31. de la Maza LM and Peterson EM. Vaccines for Chlamydia trachomatis infections. Curr Opin Investig Drugs 2002, 3:980-986.
32. Sun G, Pal S, Weiland J, Peterson EM and de la Maza LM. Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein. Vaccine 2009, 27:5020-5025.
33. Pal S, Peterson EM and de la Maza LM. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect Immun 2005, 73:8153-8160.
34. Pal S, Peterson EM, Rappuoli R, Ratti G and de la Maza LM. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge. Vaccine 2006, 24:766-775.